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The purpose of the study was to evaluate urinary citrate/creatinine (UCi/UCr) and
urinary calcium/citrate (UCa/UCi) ratios for distinguishing stone formers (SF) from nonstone formers (NSF) in an at-risk population. This was a retrospective study that
included all pediatric patients who underwent urinary citrate testing from April 2017 to
March 2018. The urinary levels of citrate, calcium, sodium, potassium, creatinine,
oxalate, urate, pH, and speciﬁc gravity (SG) were measured in our clinical laboratory.
Diagnosis of kidney stones was obtained through chart review.
A total of 97 patients were included (46 NSF and 51 SF). The UCi/UCr ratio was not
signiﬁcantly different between NSF and SF. Median UCa/UCr ratio was higher in SF (0.67)
compared with NSF (0.21, p < 0.0001). The median ratio of UCa/UCi was also higher in
SF (1.30) than in NSF (0.65, p ¼ 0.001). Oxalate, urate, pH, SG, and urinary sodium/
potassium ratio did not differentiate between the SF and NSF. Positive correlation was
seen between UCa/UCr and urinary sodium/creatinine UNa/UCr (p < 0.0001), as well as
between UCa/UCr and UCi/UCr (p < 0.0001).
The study has demonstrated signiﬁcantly higher UCa/UCi and UCa/UCr in SF compared
with NSF, while the use of urinary oxalate, urate, pH, and SG did not differentiate
between SF from NSF. We also conﬁrmed a positive correlation between UNa/UCr and
UCa/UCr. While the utility of UCa/UCr is well established, our data suggest that UCa/UCi
rather than UCi/UCr may be more predictive in the clinical setting when evaluating for
nephrolithiasis.
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Introduction
The prevalence of urolithiasis is increasing around the world,
especially among children.1 Citrate can inhibit stone formation by forming a chelate complex with calcium in the urine,
thereby inhibiting spontaneous nucleation and preventing
the growth of crystals.2 Hypocitraturia is a well-recognized
risk factor for the development of kidney stones,2 and it is
identiﬁed as a metabolic abnormality in 20 to 60% of adult
stone formers (SF).2,3 In children, the demographics of
nephrolithiasis have been changing1 and hypocitraturia
has now emerged as the most prevalent reason for nephrolithiasis in children.4,5 Contributing to the development of
hypocitraturia are distal renal tubular acidosis, hypokalemia,
bowel dysfunction, and a high-protein and low-alkali diet.2
The gold standard for the diagnosis of hypocitraturia is a
24-hour urine collection and it is deﬁned as urinary citrate
excretion < 320 mg (1.67 mmol) per 24 hours for adults.6 In
children, 24-hour urine collections are notoriously unreliable.7
Although age-dependent reference intervals for urinary citrate
to creatinine ratios (UCi/UCr) have been established,8 our own
experience of the diagnostic yield of hypocitraturia to differentiate SF from non-SF (NSF) has been low. Höbarth and
Hofbauer also suggested a limited value for UCi/UCr.9
Recent studies have suggested that urinary calcium to
citrate ratio (UCa/UCi) would be a superior marker to identify
those at risk of urolithiasis.10–13 Sikora et al.14 compared the
yield of UCa/UCi as compared with hypercalciuria and hypocitraturia for the identiﬁcation of SF in children and found
UCi/UCr to be superior; however, no precise cutoffs were
determined. As the topic is understudied, we performed a
retrospective study to evaluate the utility of UCa/UCi to
identify stone formation in a pediatric population. We also
wanted to determine the diagnostic cutoff values including
state-of-the-art Youden’s index calculation for UCi/UCr, to
determine the best reporting of risk factors for children with
nephrolithiasis. We hypothesized that the UCa/UCi in a spot
urine would differentiate between SF and NSF patients.

Materials and Methods
Study Design
This retrospective cohort study adhered to the Declaration of
Helsinki and was approved without the need to obtain
written informed consents by the Research Ethics Board of
the University of Western Ontario (REB no.109434). The
study was conducted at the Children’s Hospital of London
Health Sciences Centre (LHSC); a teaching hospital for the
University of Western Ontario.
The LHSC is a tertiary referral center with a catchment
area of 629,000 children and youths in Southern and Northwestern Ontario in Canada. The population is predominantly
Caucasian, with a 15% Middle Eastern minority, < 5% indigenous population, and a very small African-American population. All patients from the pediatric nephrology clinic who
had at least one urinary citrate ordered from April 2017 to
March 2018 were eligible for the study. Patients were classiﬁed as either having conﬁrmed nephro- or urolithiasis (SF) or
Journal of Child Science
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not (NSF) based on the presence of urolithiasis on ultrasound
or other imaging modalities (computed tomography and Xray studies); and stone analysis for those who spontaneously
passed stones prior to imaging. If more than one measurement was available per patient, we only used the earliest
measurement within the study period to reduce the impact
of any intervention such as changes in lifestyle.

Experimental Methods
Patients were identiﬁed through the Laboratory Information
System at LHSC. The spot urinary levels of citrate, calcium,
sodium, potassium, creatinine, oxalate, urate, pH, speciﬁc
gravity, diagnoses of stone formation, and ultrasound ﬁndings were obtained through review of physical charts and
electronic medical records. Methods for the urinary biomarkers have been previously published.15 Values were reported
in standard international units. Urinary citrate was measured enzymatically using a BEN-Biochemical Enterprise
(Milano, Italy) diagnostic kit.

Statistical Methods
Data analysis was performed using GraphPad Prism 5 for Mac
OS X (GraphPad Inc., San Diego, California, United States,
version 5.0f). Normal distribution was tested using the D’Agostino & Pearson omnibus normality test. Normally distributed
parameters were analyzed using parametric tools; otherwise,
nonparametric tools were used to report median, and 25th and
75th percentiles. For correlation analysis, we used the Pearson
correlation coefﬁcient. The diagnostic performance of all
urinary parameters and urinary ratios was assessed using
receiver-operated-characteristics (ROC) plots. To compare
ROC curves, we used the method proposed by Hanley.16
Youden’s index was used to calculate the optimal cutoff value
for the identiﬁcation of stone formation (UCa/UCi).17 No adjustments were made for missing values. The missing data values
were predominantly UNa, UK, and UOxalate.

Theory/Calculation
Youden’s statistic, Gini index, chi-square statistic, relative
risk, and kappa statistic all theoretically recover a true
threshold.18 While chi-square statistic and Gini index may
have the smallest bias, Youden’s statistics are deemed best
when the probability is larger.18 Therefore, Youden’s index
was used in this study.

Results
A total of 97 patients were reviewed with 46 NSF and 51 SF
patients. Patient characteristics are provided in ►Table 1. The
indications for spot urine testing in our study population were
as follows: all patients in the SF group had nephrolithiasis, 11
(25%) of the NSF group had microscopic hematuria, 8 (17%) had
glomerulonephritis, 7(15%) had a tubulopathy, 7(15%) had
congenital anomalies of the kidneys and urinary tract (CAKUT),
5(11%) had urinary tract infections, 2(4%) had metabolic syndrome, and 6(13%) had miscellaneous diagnoses (dysfunctional
voiding, primary enuresis, cystic ﬁbrosis, neuroblastoma, chromium intoxication, and failure to thrive). The reasons for
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Table 1 Patients’ characteristics and comparison of parameters
Group

SF

NSF

Comparison

Test

Number of patients

51

46

Age (y) (median, IQR)

8 (3,15)

10 (6.8, 15)

0.1755

Mann–Whitney U test

Female (%)

19 (37.3%)

22 (47.8%)

0.3074

Fisher’s exact test

Urinary citrate (mmol/L) (median, IQR)

1.55 (0.95, 2.32)

1.675 (0.79, 3.13)

0.7743

Mann–Whitney U test

Urinary calcium (mmol/L) (median, IQR)

1.87 (1.21, 4.29)

1.0 (0.26, 2.3)

0.0021

Mann–Whitney U test

Urinary sodium (mmol/L) (median, IQR)

77 (30, 121)

107 (48, 154)

0.0963

Mann–Whitney U test

Urinary potassium (mmol/L), (median, IQWR)

42 (28, 101)

48 (19, 80)

0.9895

Mann–Whitney U test

Urinary creatinine (µmol/L), (median, IQR)

3.4 (1.5, 6.8)

4.6 (1.9, 9.0)

0.3878

Mann–Whitney U test

Urinary oxalate (µmol/L), (median, IQR)

189 (111, 291)

134 (38, 290)

0.1438

Mann–Whitney U test

Urinary urate (µmol/L), (median, IQR)

1.9 (1, 5.7)

2.3 (1, 12)

0.2544

Mann–Whitney U test

Urinary pH (mean  SD)

6.6  0.91

6.5  0.98

0.7366

Student’s t-test

Urinary-speciﬁc gravity (median and IQR)

1.010
(1.005, 1.020)

1.015
(1.005, 1.020)

0.1842

Mann–Whitney U test

Urinary citrate/creatinine
(mmol/mmol) (median, IQR)

0.48 (0.21, 0.90)

0.38 (0.21, 0.86)

0.8784

Mann–Whitney U test

Urinary calcium/creatinine
(mmol/mmol) (median, IQR)

0.67 (0.31, 1.37)

0.24 (0.11, 0.73)

0.0029

Mann–Whitney U test

Urinary calcium/citrate
(mmol/mmol) (median, IQR)

1.30 (0.73, 2.78)

0.68 (0.29, 1.83)

0.0114

Mann–Whitney U test

Urinary sodium/potassium
(mmol/mmol) (mean  SD)

2.08  1.92

2.50  1.36

0.3185

Student’s t-test

Abbreviations: IQR, interquartile range; NSF, non-stone former; SD, standard deviation.
Glossary for Table 1: IQR (25th and 75th percentiles).
Note: Statistically signiﬁcant differences were bolded. The comparison column represents the p-value, and in the test column, the test that was used is
listed (based on the distribution and data type).

ordering urinary citrate in the 35 patients who did not have
microscopic hematuria were not stated. SF did not differ from
NSF regarding age, gender, urinary citrate, urinary sodium,
urinary potassium, urinary creatinine, urinary oxalate, urinary
urate, urinary pH, urinary speciﬁc gravity, UCi/UCr, and urinary
sodium/potassium ratio (UNa/UPa) (►Table 1). Statistically signiﬁcant differences only existed for the UCa/UCr, urinary UCa/UCi,
and urinary calcium concentration.
In our population, a diagnosis of hypocitraturia was not
predictive of stone formation (4 of the NSF vs. 7 of the SF had
hypocitraturia, p ¼ 0.5283). We then examined correlations
previously tested in the literature. There was a statistically
signiﬁcant positive correlation between the UCa/UCr and
urinary sodium/creatinine ratio (UNa/UCr) (Pearson
r2 ¼ 0.5099, p < 0.0001). In contrast to the expected negative correlation between the UCa/UCr and the urinary potassium/creatinine ratio (UPa/UCi), a weak positive correlation
(Pearson r2 ¼ 0.126, p ¼ 0.0036) was demonstrated. UCa/UCr
also correlated positively but weakly with UCi/UCr (Pearson
r2 ¼ 0.1180, p ¼ 0.0007). In addition, UCa/UCr correlated
positively with UCa/UCi (Pearson r2 ¼ 0.5511, p < 0.0001).
Furthermore, we determined the ROC area of the SF versus
NSF group. Useful discrimination between SF and NSF existed
for UCa/UCr (ROC area 0.7361  0.05109 with a 95% conﬁdence
interval between 0.636 and 0.836, p < 0.0001) and for UCa/UCi
(ROC area 0.6965  0.05418 with a 95% conﬁdence interval

between 0.590 and 0.803, p ¼ 0.00098). The ROC areas for UCa/
UCr and UCa/UCi did not differ (p ¼ 0.5029). The UCi/UCr ROC area
was 0.5603  0.05942, with a 95% conﬁdence interval between
0.444 and 0.677, p ¼ 0.3112.
Youden’s Index derived from the ROC curves showed that a
UCa/UCi ratio >0.68 mmol/mmol was associated with stone
formation (►Fig. 1). When differentiating SF and NSF, 10 (20%)
SF patients had an UCa/UCi ratio < 0.68 compared with 27
(58%) NSF, while 39 (80%) SF had UCa/UCi ratio > 0.68 as
compared with 19 (42%) NSF patients (p < 0.001). The diagnostic sensitivity at this cutoff was 80% and the speciﬁcity was
59%. When repeating this analysis for UCa/UCr, 24 (47%) SF
patients had an UCa/UCr ratio < 0.60 as compared with 36
(78%) NSF, while 27 (53%) SF had UCa/UCr ratio > 0.60 as
compared with 10 (22%) NSF patients (p ¼ 0.0018). The
patients were not the same. Only 10 patients had both
hypercalciuria and unfavorably high UCa/UCr (►Fig. 2). As
can be seen from ►Fig. 2, only 10 patients had both an elevated
UCa/UCi and UCa/UCr. Both ratios differentiate between NSF and
SF, with UCa/UCi actually providing a stronger discrimination,
however, the two ratios identiﬁed different populations.

Discussion
The role of the pediatric nephrologist is to identify and
diagnose modiﬁable causes of nephro- or urolithiasis. While
Journal of Child Science
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Fig. 1 Cutoff for urinary calcium/citrate (U Ca /U Ci ) using Youden’s index derived from the U Ca/U Ci ROC curve. ROC, receiver operated
characteristics.

Fig. 2 Comparison of patients’ urinary calcium/citrate (U Ca /U Ci ) and calcium/creatinine (UCa/U Cr). Stone formers are marked in black circles,
whereas non-stone formers are marked in open squares. As can be seen only 10 patients had both an elevated UCa/U Ci and U Ca /U Cr. Both ratios
differentiate between NSF and SF, but they identify differing populations. NSF, non-stone formers; SF, stone formers.

many factors contribute to nephro- or urolithiasis, the
current recommended approach is the use of UCa/UCr and
UCi/UCr for distinguishing SF from NSF. In this study, we found
a low diagnostic yield for UCi/UCr, similar to Höbarth and
Hofbauer.9 This low yield could be associated with the
Journal of Child Science
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complexities of lithogenesis. The identiﬁcation of a single
metabolic factor may provide insufﬁcient information for
diagnosis, therapeutic, and preventive measures.14 In contrast, UCa/UCr and UCa/UCi had a reasonable diagnostic performance as shown in the ROC areas. However, both ratios

Citrate/Creatinine or Calcium/Citrate Ratio
identiﬁed different patient cohorts, and only 10 of the SF had
both elevated UCa/UCr and UCa/UCi.
The present study suggests that elevated UCa/UCi is an
independent risk factor for stone formation, rather than
hypocitraturia. In other words, what promotes stone formation may not be the absolute citrate deﬁciency, but rather
insufﬁcient citrate for a given calcium concentration. Parks
and Coe19 found in adults with urolithiasis a higher level of
urine calcium for any given level of urine citrate, while
Cupisti et al suggested that this relation was higher in
recurrent SF.20
After establishing Youden’s index for the cutoff point and
p-values, UCa/UCi was more predictive of stone formation
than UCa/UCr. However, populations with hypercalciuria and
hypocitraturia correspond with different etiologies for
lithogenesis, suggesting that both ratios may be useful
biomarkers and may both be needed for assessing overall
patient risk.
We did not assess whether potassium citrate therapy
versus hydrochlorothiazide would be better therapies. However, hydrochlorothiazide treatment tends to reduce serum
potassium, increase uric acid levels, and lower urinary citrate
excretion.21 These side effects may actually contravene the
urinary calcium-lowering effect, whereas the adverse effects
of potassium citrate are limited to abdominal distension,
diarrhea, nausea, and abdominal pain.22 Supplementation of
citrate may be safer than the use of hydrochlorothiazide for
decreasing the risk of nephrolithiasis in hypercalciuria.
In Canada, treatment with hydrochlorothiazide is most
commonly prescribed for hypercalciuria because potassium
citrate is not covered. Others have used lemon juice as an
alternative to potassium citrate. Kang et al23 found an
increase in urinary citrate levels and a decrease in the stone
formation rates in 11 adults after 44 months of lemonade
therapy consisted of 120 mL concentrated lemon juice (5.9 g
citric acid) mixed with 2L of water throughout each day.23
Penniston et al24 compared grape, orange, lime, and lemon
juice both from fresh fruit and from juice concentrates and
found that lime and lemon provide more citric acid per liter
than others.24
Several papers have identiﬁed that UCa/UCi may be preferable for the identiﬁcation of SF.10–13,25 Using Youden’s
index, a cutoff of UCa/UCi ratio > 0.68 mmol/mmol was
determined for the identiﬁcation of SF. Arrabal-Polo et al12
suggested a cutoff of 0.25 mg/mg (which would be 1.2 mmol/
mmol) to identify recurrent SF; however, the authors did not
use a standardized method for deriving the cutoff. The only
other study on children by Turudic et al suggests that a UCa/
UCi ratio below 0.61 mmol/mmol would identify healthy
children,26 but again without any analysis beyond a subjective ROC curve inspection. Our cutoff value of 0.68 mmol/
mmol is very similar to that of Turudic et al, albeit determined by more statistically sound methods.
The study has several limitations, including the retrospective nature of the study, the number of patients and a
few (maximum 8 per parameter) missing urine electrolytes
(mostly potassium and sodium owing to the retrospective
nature and lack of a prospective stone workup protocol).
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Also, there may have been a selection bias because only
pediatric nephrology patients were recruited, rather than
the general population. We did not utilize 24-hour urine
collections even though these may be more accurate; however, they are notoriously unreliable in children.27 Additionally in the NSF we did not control for pre-existing
conditions that may have an increased risk for kidney
stones such as comorbidities like inﬂammatory bowel disease, need for tube feeds, or cystic ﬁbrosis. One patient in
the control group had cystic ﬁbrosis, but no hematuria.
Furthermore, while only the earliest measurement in a time
period was used, not all patients actually had measurements preintervention. We also realize that kidney stones
in low-income countries may be more commonly formed by
uric acid or ammonium. This could decrease the utility of
UCa/UCi to identify SF in those countries.28 Nonetheless, the
previously proposed cutoffs of around 0.68 mmol/mmol
have been solidiﬁed. As the sensitivity at this cutoff was 80%
and the speciﬁcity was 59%, future prospective studies
should validate this cutoff.

Conclusion
This study adds to the growing body of literature supporting
both the reporting and use of UCa/UCi instead of UCi/UCr to
identify pediatric SF and through an appropriate statistical
method propose a cutoff of 0.68 mmol/mmol. Given the
results of our analysis, we propose for pediatric patients
with nephro- or urolithiasis that an initial urinary workup
includes urinary creatinine, urinary calcium, and urinary
citrate, in addition to the inexpensive urinary sodium and
potassium. The authors further propose the use of UCa/UCi to
identify patients at risk of urolithiasis and possibly for
initiation of treatment with potassium citrate or even lemon
juice. Future prospective studies would be important to
validate the ﬁndings.
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